NanoscaleHumansCentral Nervous System DiseasesAnimalsNanomedicineDrug Delivery Systems
Challenges and opportunities in nanotherapeutics targeted for central nervous system disorders.
Joel Yong, Karen Hakobyan, Sk Al Zaheri Mahmud, Daniel James Johnson, Jacob Lee, Ashish D Diwan, Sophia Gu, Gila Moalem-Taylor, Guangzhao Mao
Published: 202510.1039/d5nr02463c
Abstract
Central nervous system (CNS) disorders represent some of the most challenging problems for modern medicine. The complexity of the CNS structure, incomplete understanding of disease, chronic neuroinflammation, and physiological barriers limiting drug…
Preview only. Read the full abstract at the source